In this context, a phase I clinical trial (60) analyzed 155 samples of CC to explore the potential relationship between PD-L1 expression and histology; the findings suggested that both immune cell presence and PD-L1 expression in tumor cells were more common in squamous cell carcinomas than adenocarcinomas. The gene discussed is CD274; the disease is adenocarcinoma.